Clinical trial
The Predictive Role of HPV Integration in HSIL and Cervical Cancer
NCT05300243 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Predictive Role of HPV Integration in HSIL and Cervical Cancer
- Lead sponsor
- Tongji Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 7, 2020
- Completion date
- June 1, 2022
- Enrollment
- 1 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hpv integration